Bayer AG
www.bayer.com
Latest From Bayer AG
Primatene Mist NDA Expected By July After FDA OKs OTC Asthma Inhaler Trial
PEG 3350 Laxatives: FDA Allows Firms 6 Months To Make Their Case For Rx Products
FDA agrees with Breckenridge Pharmaceutical, Nexgen Pharma, Lannett Co. and Paddock Labs that ending availability of their Rx PEG 3350 products on May 2 would cause a shortage of the drug available to consumers. Saying "it likely would be difficult for manufacturers of OTC PEG 3350 products to compensate for the removal" of the Rx drugs by that date, FDA extends the deadline to Nov. 2.
Rx PEG Firms Give FDA Deadline Before Asking Court To Delay ANDA Withdrawals
Breckenridge Pharmaceuticals and Nexgen Pharma file a citizen petition asking FDA to delay effective date for the agency's order that withdrawing approval of all abbreviated new drug applications for Rx generic polyethylene glycol 3350 laxatives. Absent quick reply, the companies may seek emergency court action.
Giant LEAPS For Mankind: Bayer's Malik On Breaking The Mold In R&D
As new scientific breakthroughs are shaking the foundations of pharma and biotech R&D, In Vivo sat down with Bayer's Kemal Malik to hear how the German big pharma is responding to the challenges with its ground-breaking LEAPS program.
Company Information
- Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
- Radiopharmaceuticals, Contrast Agents
- Therapeutic Areas
- Blood & Coagulation Disorders & Products
- Cancer
- Cardiovascular
- Dermatology
- Gynecological, Urological
- Metabolic Disorders
- Neurology, Nervous System
- Ophthalmic
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Germany
-
Germany
-
Western Europe
-
Europe
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
Bayer AG
- Algeta ASA
-
Bayer Corp.
-
Bayer HealthCare LLC
- Bayer Biological Products
- Bayer Consumer Care
-
Bayer HealthCare Pharmaceuticals AG
- Direvo Biotech AG
-
Schering AG
- Berlex Laboratories Oncology Unit
- Collateral Therapeutics Inc.
- Diatide Research Laboratories
- Leiras Norge AS
- Oy Leiras Finland AB
- Steripak Ltd.
- Asche AG
- Berlex Biosciences
- Berlex Inc.
- Berlex Laboratories Inc.
- Leiras Oy
- MAP Medical Technologies Oy
- Mitsui Pharmaceuticals Inc.
- Nihon Schering KK
- Schering Berlin Inc.
- Schering Berlin Venture Corp.
- Schering Espana SA
- Schering Health Care Ltd.
- Bayer Medical Care Inc.
- Bayer Schering Pharma AG
- Bayer Yakuhin Ltd.
- Conceptus Inc.
- Dermatology Inc.
- Roche Consumer Health
-
Bayer HealthCare LLC
- Bayer CropScience LP
- Bayer HealthCare AG
- Bayer Inc.
- Bayer Innovation GMBH
- Bayer Korea Ltd.
- Bayer MaterialScience AG
- Bayer Technology Services GMBH
- ChemDesign Corp.
- Cooper Technicon Inc.
- Cutter Biological
- Miles Biotechnology Inc.
- Miles Dental Products
- Miles Hollister-Stier
- Miles-Sankyo Co. Ltd.
- Mobay Corp. Animal Health Division
- Molecular Diagnostics Inc.
- Pentex
- Steigerwald Arzneimittelwerk GMBH
- Technicon Industrial Group
- Technicon Instrument Corp.
- Senior Management
-
Marijn E Dekkers, PhD, Chmn. & CEO
Werner Baumann, CFO - Contact Info
-
Bayer AG
Phone: (49) 214 30 1
Werk Leverkusen
Leverkusen, D-51368
Germany
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice